Cellular and Molecular Life Sciences

, Volume 69, Issue 12, pp 1917–1929 | Cite as

Deciphering the structure and function of FcεRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm

Review

Abstract

Allergy and anaphylaxis are inflammatory disorders caused by immune reactions mainly induced by immunoglobulin-E that signal through the high-affinity FcεRI receptor to release the inflammatory mediators from innate immune cells. The FcεRI/mast cell axis is potently involved in triggering various intracellular signaling molecules to induce calcium release from the internal stores, induction of transcription factors such as NF-kB, secretion of various cytokines as well as lipid mediators, and degranulation, resulting in the induction of allergy and anaphylaxis. In this review, we discuss various cellular and molecular mechanisms triggered through FcεRI/mast cell axis in allergy and anaphylaxis with a special emphasis on the functional genomics paradigm.

Keywords

Allergy Anaphylaxis FcεRI IgE Cytokines Transcription Factors Functional Genomics 

References

  1. 1.
    MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM (1995) Molecular identification of an IgE-dependent histamine-releasing factor. Science 269(5224):688–690PubMedGoogle Scholar
  2. 2.
    Portier P, Richet C (1902) De l’action anaphylatique de certain venins. C R Soc Biol 54:170Google Scholar
  3. 3.
    Theoharides TC, Kalogeromitros D (2006) The critical role of mast cells in allergy and inflammation. Ann NY Acad Sci 1088:78–99PubMedGoogle Scholar
  4. 4.
    Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A, Kalogeromitros D (2010) Mast cells and inflammation. Biochim Biophys Acta. doi:10.1016/j.bbadis.2010.12.014
  5. 5.
    Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77(4):1033–1079PubMedGoogle Scholar
  6. 6.
    Munitz A, Piliponsky AM, Levi-Schaffer F (2003) IgE-independent activation of human mast cells indicates their role in the late-phase reaction of allergic inflammation. Cell Tissue Bank 4(1):25–28PubMedGoogle Scholar
  7. 7.
    Dudler T, Machado DC, Kolbe L, Annand RR, Rhodes N, Gelb MH, Koelsch K, Suter M, Helm BA (1995) A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2. J Immunol 155(5):2605–2613PubMedGoogle Scholar
  8. 8.
    Sullivan TJ, Hart DA, Streilein JW (1981) IgE-dependent release of inflammatory mediators from hamster mast cells in vitro. Adv Exp Med Biol 134:33–41PubMedGoogle Scholar
  9. 9.
    Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW (1997) Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 94(6):2150–2155PubMedGoogle Scholar
  10. 10.
    Firoved AM, Ornatowski W, Deretic V (2004) Microarray analysis reveals induction of lipoprotein genes in mucoid pseudomonas aeruginosa: implications for inflammation in cystic fibrosis. Infect Immun 72(9):5012–5018PubMedGoogle Scholar
  11. 11.
    Spears R, Oakes R, Moore C, Bellinger LL, Hutchins B (2003) A determination of tumor necrosis factor expression in TMJ inflammation with the use of microarray analysis. J Dent Res 82(10):807–813PubMedGoogle Scholar
  12. 12.
    Olman MA, White KE, Ware LB, Cross MT, Zhu S, Matthay MA (2002) Microarray analysis indicates that pulmonary edema fluid from patients with acute lung injury mediates inflammation, mitogen gene expression, and fibroblast proliferation through bioactive interleukin-1. Chest 121((3 Suppl)):69S–70SPubMedGoogle Scholar
  13. 13.
    Gu J, Huang F, Yu D (2001) Analysis of inflammation related gene expression spectrum in ankylosing spondylitis patients using cDNA microarray. Zhonghua Yi Xue Za Zhi 81(17):1030–1034PubMedGoogle Scholar
  14. 14.
    Daeron M (1997) Fc receptor biology. Annu Rev Immunol 15:203–234PubMedGoogle Scholar
  15. 15.
    Unkeless JC, Scigliano E, Freedman VH (1988) Structure and function of human and murine receptors for IgG. Annu Rev Immunol 6:251–281PubMedGoogle Scholar
  16. 16.
    Ravetch JV, Kinet JP (1991) Fc receptors. Annu Rev Immunol 9:457–492PubMedGoogle Scholar
  17. 17.
    Vitetta ES, Uhr JW (1975) Immunoglobulin-receptors revisited. Science 189(4207):964–969PubMedGoogle Scholar
  18. 18.
    Davie JM (1975) Immunoglobulin receptors in lymphocytes. Adv Pathobiol (1):70–79Google Scholar
  19. 19.
    Keegan AD, Conrad DH (1990) The receptor for the Fc region of IgE. Springer Semin Immunopathol 12(4):303–326PubMedGoogle Scholar
  20. 20.
    Gould HJ, Sutton BJ, Beavil AJ, Beavil RL, McCloskey N, Coker HA, Fear D, Smurthwaite L (2003) The biology of IGE and the basis of allergic disease. Annu Rev Immunol 21:579–628PubMedGoogle Scholar
  21. 21.
    Rosenwasser LJ, Meng J (2005) Anti-CD23. Clin Rev Allergy Immunol 29(1):61–72PubMedGoogle Scholar
  22. 22.
    MacGlashan D Jr (2008) IgE receptor and signal transduction in mast cells and basophils. Curr Opin Immunol 20(6):717–723PubMedGoogle Scholar
  23. 23.
    Gilfillan AM, Rivera J (2009) The tyrosine kinase network regulating mast cell activation. Immunol Rev 228(1):149–169PubMedGoogle Scholar
  24. 24.
    Rivera J, Fierro NA, Olivera A, Suzuki R (2008) New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol 98:85–120PubMedGoogle Scholar
  25. 25.
    Kinet JP (1999) The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 17:931–972PubMedGoogle Scholar
  26. 26.
    Stingl G, Maurer D (1997) IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells. Int Arch Allergy Immunol 113(1–3):24–29PubMedGoogle Scholar
  27. 27.
    Uehara M, Sawai T (1989) Familial background of respiratory atopy. A factor of type I allergy to house dust mite in patients with atopic dermatitis. Arch Dermatol 125 (7):939–943Google Scholar
  28. 28.
    Smith SJ, Ying S, Meng Q, Sullivan MH, Barkans J, Kon OM, Sihra B, Larche M, Levi-Schaffer F, Kay AB (2000) Blood eosinophils from atopic donors express messenger RNA for the alpha, beta, and gamma subunits of the high-affinity IgE receptor (Fc epsilon RI) and intracellular, but not cell surface, alpha subunit protein. J Allergy Clin Immunol 105 (2 Pt 1):309–317Google Scholar
  29. 29.
    Conrad DH, Campbell KA, Bartlett WC, Squire CM, Dierks SE (1994) Structure and function of the low affinity IgE receptor. Adv Exp Med Biol 347:17–30PubMedGoogle Scholar
  30. 30.
    Donnadieu E, Jouvin MH, Kinet JP (2000) A second amplifier function for the allergy-associated Fc (epsilon) RI-beta subunit. Immunity 12(5):515–523PubMedGoogle Scholar
  31. 31.
    Nadler MJ, Matthews SA, Turner H, Kinet JP (2000) Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function. Adv Immunol 76:325–355PubMedGoogle Scholar
  32. 32.
    Kraft S, Bieber T (2001) Fc epsilon ri-mediated activation of transcription factors in antigen-presenting cells. Int Arch Allergy Immunol 125(1):9–15PubMedGoogle Scholar
  33. 33.
    Miller L, Blank U, Metzger H, Kinet JP (1989) Expression of high-affinity binding of human immunoglobulin E by transfected cells. Science 244(4902):334–337PubMedGoogle Scholar
  34. 34.
    Kawakami T, Galli SJ (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2(10):773–786PubMedGoogle Scholar
  35. 35.
    Jonsson F, Mancardi DA, Kita Y, Karasuyama H, Iannascoli B, Van Rooijen N, Shimizu T, Daeron M, Bruhns P (2011) Mouse and human neutrophils induce anaphylaxis. J Clin Invest 121(4):1484–1496PubMedGoogle Scholar
  36. 36.
    Reynolds DS, Serafin WE, Faller DV, Wall DA, Abbas AK, Dvorak AM, Austen KF, Stevens RL (1988) Immortalization of murine connective tissue-type mast cells at multiple stages of their differentiation by coculture of splenocytes with fibroblasts that produce Kirsten sarcoma virus. J Biol Chem 263(25):12783–12791PubMedGoogle Scholar
  37. 37.
    Xu D, Jiang HR, Li Y, Pushparaj PN, Kurowska-Stolarska M, Leung BP, Mu R, Tay HK, McKenzie AN, McInnes IB, Melendez AJ, Liew FY (2010) IL-33 exacerbates autoantibody-induced arthritis. J Immunol 184(5):2620–2626PubMedGoogle Scholar
  38. 38.
    Eady RA (1976) The mast cells: distribution and morphology. Clin Exp Dermatol 1(4):313–321PubMedGoogle Scholar
  39. 39.
    Metcalfe DD (2008) Mast cells and mastocytosis. Blood 112(4):946–956PubMedGoogle Scholar
  40. 40.
    Liew FY, Pitman NI, McInnes IB (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10(2):103–110PubMedGoogle Scholar
  41. 41.
    Kopec A, Panaszek B, Fal AM (2006) Intracellular signaling pathways in IgE-dependent mast cell activation. Arch Immunol Ther Exp (Warsz) 54(6):393–401Google Scholar
  42. 42.
    Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, Siraganian RP, Krystal G (2001) Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14(6):801–811PubMedGoogle Scholar
  43. 43.
    Baumruker T, Prieschl EE (2000) The role of sphingosine kinase in the signaling initiated at the high-affinity receptor for IgE (FcepsilonRI) in mast cells. Int Arch Allergy Immunol 122(2):85–90PubMedGoogle Scholar
  44. 44.
    Beaven MA, Metzger H (1993) Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol Today 14(5):222–226PubMedGoogle Scholar
  45. 45.
    Barnes PJ, Chung KF, Page CP (1998) Inflammatory mediators of asthma: an update. Pharmacol Rev 50(4):515–596PubMedGoogle Scholar
  46. 46.
    Gilfillan AM, Tkaczyk C (2006) Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6(3):218–230PubMedGoogle Scholar
  47. 47.
    Kambayashi T, Koretzky GA (2007) Proximal signaling events in Fc epsilon RI-mediated mast cell activation. J Allergy Clin Immunol 119 (3):544–552; (quiz 553-544)Google Scholar
  48. 48.
    Kitaura J, Eto K, Kinoshita T, Kawakami Y, Leitges M, Lowell CA, Kawakami T (2005) Regulation of highly cytokinergic IgE-induced mast cell adhesion by Src, Syk, Tec, and protein kinase C family kinases. J Immunol 174(8):4495–4504PubMedGoogle Scholar
  49. 49.
    Rivera J (2002) Molecular adapters in Fc(epsilon)RI signaling and the allergic response. Curr Opin Immunol 14(6):688–693PubMedGoogle Scholar
  50. 50.
    Turner H, Kinet JP (1999) Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 402(6760 Suppl):B24–B30PubMedGoogle Scholar
  51. 51.
    Goldstein B, Faeder JR, Hlavacek WS, Blinov ML, Redondo A, Wofsy C (2002) Modeling the early signaling events mediated by FcepsilonRI. Mol Immunol 38(16–18):1213–1219PubMedGoogle Scholar
  52. 52.
    Craig AW, Zirngibl R, Williams K, Cole LA, Greer PA (2001) Mice devoid of fer protein-tyrosine kinase activity are viable and fertile but display reduced cortactin phosphorylation. Mol Cell Biol 21(2):603–613PubMedGoogle Scholar
  53. 53.
    Choi OH, Kim JH, Kinet JP (1996) Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor. Nature 380(6575):634–636PubMedGoogle Scholar
  54. 54.
    Aarthi JJ, Darendeliler MA, Pushparaj PN (2011) Dissecting the role of S1P/S1PR axis in health and disease. J Dent Res 90(7):841–854Google Scholar
  55. 55.
    Jolly PS, Bektas M, Olivera A, Gonzalez-Espinosa C, Proia RL, Rivera J, Milstien S, Spiegel S (2004) Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. J Exp Med 199(7):959–970PubMedGoogle Scholar
  56. 56.
    Urtz N, Olivera A, Bofill-Cardona E, Csonga R, Billich A, Mechtcheriakova D, Bornancin F, Woisetschlager M, Rivera J, Baumruker T (2004) Early activation of sphingosine kinase in mast cells and recruitment to FcepsilonRI are mediated by its interaction with Lyn kinase. Mol Cell Biol 24(19):8765–8777PubMedGoogle Scholar
  57. 57.
    Malveaux FJ, Conroy MC, Adkinson NF, Jr., Lichtenstein LM (1978) IgE receptors on human basophils. Relationship to serum IgE concentration. J Clin Invest 62 (1):176–181Google Scholar
  58. 58.
    Hsu C, MacGlashan D Jr (1996) IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol Lett 52(2–3):129–134PubMedGoogle Scholar
  59. 59.
    Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajima I, Kinet JP, Galli SJ (1997) IgE regulates mouse basophil Fc epsilon RI expression in vivo. J Immunol 158(6):2517–2521PubMedGoogle Scholar
  60. 60.
    Yamaguchi M, Sayama K, Yano K, Lantz CS, Noben-Trauth N, Ra C, Costa JJ, Galli SJ (1999) IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J Immunol 162(9):5455–5465PubMedGoogle Scholar
  61. 61.
    Woolhiser MR, Okayama Y, Gilfillan AM, Metcalfe DD (2001) IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur J Immunol 31(11):3298–3307PubMedGoogle Scholar
  62. 62.
    Gurish MF, Bryce PJ, Tao H, Kisselgof AB, Thornton EM, Miller HR, Friend DS, Oettgen HC (2004) IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J Immunol 172(2):1139–1145PubMedGoogle Scholar
  63. 63.
    Oettgen HC, Geha RS (2001) IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol 107(3):429–440PubMedGoogle Scholar
  64. 64.
    Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P (1994) Active anaphylaxis in IgE-deficient mice. Nature 370(6488):367–370PubMedGoogle Scholar
  65. 65.
    Pushparaj PN, Tay HK, H’Ng SC, Pitman N, Xu D, McKenzie A, Liew FY, Melendez AJ (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci USA 106(24):9773–9778PubMedGoogle Scholar
  66. 66.
    Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin MH, Kilgus O, Kinet JP, Stingl G (1994) Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J Exp Med 179(2):745–750PubMedGoogle Scholar
  67. 67.
    Reischl IG, Dubois GR, Peiritsch S, Brown KS, Wheat L, Woisetschlager M, Mudde GC (2000) Regulation of Fc epsilonRI expression on human monocytic cells by ligand and IL-4. Clin Exp Allergy 30(7):1033–1040PubMedGoogle Scholar
  68. 68.
    Cookson WO, Sharp PA, Faux JA, Hopkin JM (1989) Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1(8650):1292–1295PubMedGoogle Scholar
  69. 69.
    Nishiyama C, Akizawa Y, Nishiyama M, Tokura T, Kawada H, Mitsuishi K, Hasegawa M, Ito T, Nakano N, Okamoto A, Takagi A, Yagita H, Okumura K, Ogawa H (2004) Polymorphisms in the Fc epsilon RI beta promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between Fc epsilon RI beta and atopy. J Immunol 173(10):6458–6464PubMedGoogle Scholar
  70. 70.
    MacGlashan D, Jr., Lichtenstein LM, McKenzie-White J, Chichester K, Henry AJ, Sutton BJ, Gould HJ (1999) Upregulation of FcepsilonRI on human basophils by IgE antibody is mediated by interaction of IgE with FcepsilonRI. J Allergy Clin Immunol 104 (2 Pt 1):492–498Google Scholar
  71. 71.
    MacGlashan D Jr, McKenzie-White J, Chichester K, Bochner BS, Davis FM, Schroeder JT, Lichtenstein LM (1998) In vitro regulation of Fc epsilon RIalpha expression on human basophils by IgE antibody. Blood 91(5):1633–1643PubMedGoogle Scholar
  72. 72.
    Borkowski TA, Jouvin MH, Lin SY, Kinet JP (2001) Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI. J Immunol 167(3):1290–1296PubMedGoogle Scholar
  73. 73.
    Toru H, Ra C, Nonoyama S, Suzuki K, Yata J, Nakahata T (1996) Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4. Int Immunol 8(9):1367–1373PubMedGoogle Scholar
  74. 74.
    Capron A, Dombrowicz D, Capron M (1999) Regulation of the immune response in experimental and human schistosomiasis: the limits of an attractive paradigm. Microbes Infect 1(7):485–490PubMedGoogle Scholar
  75. 75.
    Simon MR, Cooper KD, Norris RB, Blok B, King CL (1995) Antigen presenting cell-independent cytokine and spontaneous in vitro IgE production in patients with atopic dermatitis: increased interferon-gamma production and lack of effects of in vivo low-dose interferon-gamma treatment. J Allergy Clin Immunol 96(1):84–91PubMedGoogle Scholar
  76. 76.
    Fouilloux I, Duplan MB, Baroukh B, Cherruau M, Saffar JL, Lesclous P (2006) Mast cell activation and degranulation occur early during induction of periosteal bone resorption. Bone 38(1):59–66PubMedGoogle Scholar
  77. 77.
    Gurish MF, Ghildyal N, Arm J, Austen KF, Avraham S, Reynolds D, Stevens RL (1991) Cytokine mRNA are preferentially increased relative to secretory granule protein mRNA in mouse bone marrow-derived mast cells that have undergone IgE-mediated activation and degranulation. J Immunol 146(5):1527–1533PubMedGoogle Scholar
  78. 78.
    Morrison DC, Roser JF, Cochrane CG, Henson PM (1975) The initiation of mast cell degranulation: activation at the cell membrane. J Immunol 114(3):966–970PubMedGoogle Scholar
  79. 79.
    Kaliner M, Shelhamer JH, Ottesen EA (1982) Effects of infused histamine: correlation of plasma histamine levels and symptoms. J Allergy Clin Immunol 69(3):283–289PubMedGoogle Scholar
  80. 80.
    Morel DR, Skoskiewicz M, Robinson DR, Bloch KJ, Hoaglin DC, Zapol WM (1991) Leukotrienes, thromboxane A2, and prostaglandins during systemic anaphylaxis in sheep. Am J Physiol 261 (3 Pt 2):H782–792Google Scholar
  81. 81.
    Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, Simons FE, Simons KJ, Cass D, Yeung J (2008) Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 358(1):28–35PubMedGoogle Scholar
  82. 82.
    Pretolani M, Lellouch-Tubiana A, Lefort J, Bachelet M, Vargaftig BB (1989) PAF-acether and experimental anaphylaxis as a model for asthma. Int Arch Allergy Appl Immunol 88(1–2):149–153PubMedGoogle Scholar
  83. 83.
    Felix SB, Baumann G, Hashemi T, Niemczyk M, Ahmad Z, Berdel WE (1990) Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis. J Cardiovasc Pharmacol 15(6):987–997PubMedGoogle Scholar
  84. 84.
    Gordon JR, Galli SJ (1991) Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 174 (1):103–107Google Scholar
  85. 85.
    Comaish JS (1965) The role of the mast cells and basophils in hypersensitivity. Br J Dermatol 77:92–97PubMedGoogle Scholar
  86. 86.
    von Bubnoff D, Novak N, Kraft S, Bieber T (2003) The central role of FcepsilonRI in allergy. Clin Exp Dermatol 28(2):184–187Google Scholar
  87. 87.
    Maurer D, Ebner C, Reininger B, Petzelbauer P, Fiebiger E, Stingl G (1997) Mechanisms of Fc epsilon RI-IgE-facilitated allergen presentation by dendritic cells. Adv Exp Med Biol 417:175–178PubMedGoogle Scholar
  88. 88.
    Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML (1999) T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 20(12):561–567PubMedGoogle Scholar
  89. 89.
    Karras JG, McGraw K, McKay RA, Cooper SR, Lerner D, Lu T, Walker C, Dean NM, Monia BP (2000) Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma. J Immunol 164(10):5409–5415PubMedGoogle Scholar
  90. 90.
    Kay AB (2001) Allergy and allergic diseases. First of two parts. N Engl J Med 344 (1):30-37Google Scholar
  91. 91.
    Berin MC, Mayer L (2009) Immunophysiology of experimental food allergy. Mucosal Immunol 2(1):24–32PubMedGoogle Scholar
  92. 92.
    Muller UR (2001) New developments in the diagnosis and treatment of hymenoptera venom allergy. Int Arch Allergy Immunol 124(4):447–453PubMedGoogle Scholar
  93. 93.
    Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, Walls AF, Askenase PW, Kay AB (1999) C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 163(7):3976–3984PubMedGoogle Scholar
  94. 94.
    Robinson DS, Hamid Q, Jacobson M, Ying S, Kay AB, Durham SR (1993) Evidence for Th2-type T helper cell control of allergic disease in vivo. Springer Semin Immunopathol 15(1):17–27PubMedGoogle Scholar
  95. 95.
    Chang-Yeung M, Lam S, Kennedy SM, Frew AJ (1994) Persistent asthma after repeated exposure to high concentrations of gases in pulpmills. Am J Respir Crit Care Med 149(6):1676–1680PubMedGoogle Scholar
  96. 96.
    Arguelles M, Blanco I (1983) Inflammatory bronchial polyps associated with asthma. Arch Intern Med 143(3):570–571PubMedGoogle Scholar
  97. 97.
    Macfarlane AJ, Kon OM, Smith SJ, Zeibecoglou K, Khan LN, Barata LT, McEuen AR, Buckley MG, Walls AF, Meng Q, Humbert M, Barnes NC, Robinson DS, Ying S, Kay AB (2000) Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol 105 (1 Pt 1):99–107Google Scholar
  98. 98.
    Elmgreen J, Stahl Skov P, Permin H, Binder V, Heugh Wandall J, Norn S (1984) Type I allergy to normal cellular constituents in chronic inflammatory bowel disease? Results from basophil histamine release test compared with total IgE and antinuclear antibodies. Allergy 39(1):23–28PubMedGoogle Scholar
  99. 99.
    Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA, Bunnett NW (2000) Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6(2):151–158PubMedGoogle Scholar
  100. 100.
    Holt PG, Macaubas C, Stumbles PA, Sly PD (1999) The role of allergy in the development of asthma. Nature 402((6760 Suppl)):B12–B17PubMedGoogle Scholar
  101. 101.
    Dolovich J, Hargreave FE, Chalmers R, Shier KJ, Gauldie J, Bienenstock J (1973) Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 52(1):38–46PubMedGoogle Scholar
  102. 102.
    Milgrom H (2002) Attainments in atop: special aspects of allergy and IgE. Adv Pediatr 49:273–297PubMedGoogle Scholar
  103. 103.
    Gospos A, Dreikhausen U, Dartsch DC, Szamel M, Hockertz S (2001) Development of an allergy test model: activation of human mast cells with potentially allergenic substances. Toxicology 166(1–2):91–96PubMedGoogle Scholar
  104. 104.
    van Halteren AG, van der Cammen MJ, Biewenga J, Savelkoul HF, Kraal G (1997) IgE and mast cell response on intestinal allergen exposure: a murine model to study the onset of food allergy. J Allergy Clin Immunol 99 (1 Pt 1):94–99Google Scholar
  105. 105.
    Toru H, Pawankar R, Ra C, Yata J, Nakahata T (1998) Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol 102(3):491–502PubMedGoogle Scholar
  106. 106.
    Haselden BM, Kay AB, Larche M (1999) Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 189(12):1885–1894PubMedGoogle Scholar
  107. 107.
    Herz U, Botchkarev VA, Paus R, Renz H (2004) Increased airway responsiveness, allergy-type-I skin responses and systemic anaphylaxis in a humanized-severe combined immuno-deficiency mouse model. Clin Exp Allergy 34(3):478–487PubMedGoogle Scholar
  108. 108.
    Berger P, N’Guyen C, Buckley M, Scotto-Gomez E, Marthan R, Tunon-de-Lara JM (2002) Passive sensitization of human airways induces mast cell degranulation and release of tryptase. Allergy 57(7):592–599PubMedGoogle Scholar
  109. 109.
    Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J, Fick RB Jr, Boushey HA (1997) The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 155(6):1828–1834PubMedGoogle Scholar
  110. 110.
    Benoist C, Mathis D (2002) Mast cells in autoimmune disease. Nature 420(6917):875–878PubMedGoogle Scholar
  111. 111.
    Pachiappan A, Thwin MM, Manikandan J, Gopalakrishnakone P (2005) Glial inflammation and neurodegeneration induced by candoxin, a novel neurotoxin from Bungarus candidus venom: global gene expression analysis using microarray. Toxicon 46(8):883–899PubMedGoogle Scholar
  112. 112.
    Shen F, Ruddy MJ, Plamondon P, Gaffen SL (2005) Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol 77(3):388–399PubMedGoogle Scholar
  113. 113.
    Rundle CH, Wang H, Yu H, Chadwick RB, Davis EI, Wergedal JE, Lau KH, Mohan S, Ryaby JT, Baylink DJ (2006) Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone 38(4):521–529PubMedGoogle Scholar
  114. 114.
    Shiue HS, Lee YS, Tsai CN, Hsueh YM, Sheu JR, Chang HH (2008) DNA microarray analysis of the effect on inflammation in patients treated with acupuncture for allergic rhinitis. J Altern Complement Med 14(6):689–698PubMedGoogle Scholar
  115. 115.
    Jayapal M, Tay HK, Reghunathan R, Zhi L, Chow KK, Rauff M, Melendez AJ (2006) Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics 7:210PubMedGoogle Scholar
  116. 116.
    Saito H, Nakajima T, Matsumoto K (2001) Human mast cell transcriptome project. Int Arch Allergy Immunol 125(1):1–8PubMedGoogle Scholar
  117. 117.
    Kuramasu A, Kubota Y, Matsumoto K, Nakajima T, Sun XM, Watanabe T, Saito H, Ohtsu H (2001) Identification of novel mast cell genes by serial analysis of gene expression in cord blood-derived mast cells. FEBS Lett 498(1):37–41PubMedGoogle Scholar
  118. 118.
    Wakahara S, Fujii Y, Nakao T, Tsuritani K, Hara T, Saito H, Ra C (2001) Gene expression profiles for Fc epsilon RI, cytokines and chemokines upon Fc epsilon RI activation in human cultured mast cells derived from peripheral blood. Cytokine 16(4):143–152PubMedGoogle Scholar
  119. 119.
    Nakajima T, Matsumoto K, Suto H, Tanaka K, Ebisawa M, Tomita H, Yuki K, Katsunuma T, Akasawa A, Hashida R, Sugita Y, Ogawa H, Ra C, Saito H (2001) Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells. Blood 98(4):1127–1134PubMedGoogle Scholar
  120. 120.
    Nakamura R, Ishida S, Ozawa S, Saito Y, Okunuki H, Teshima R, Sawada J (2002) Gene expression profiling of Ca2+ -ATPase inhibitor DTBHQ and antigen-stimulated RBL-2H3 mast cells. Inflamm Res 51(12):611–618PubMedGoogle Scholar
  121. 121.
    Nakajima T, Inagaki N, Tanaka H, Tanaka A, Yoshikawa M, Tamari M, Hasegawa K, Matsumoto K, Tachimoto H, Ebisawa M, Tsujimoto G, Matsuda H, Nagai H, Saito H (2002) Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcepsilon receptor I cross-linking: an interspecies comparison. Blood 100(12):3861–3868PubMedGoogle Scholar
  122. 122.
    Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, Saito H, Okayama Y (2003) Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. Blood 102(7):2547–2554PubMedGoogle Scholar
  123. 123.
    Babina M, Guhl S, Starke A, Kirchhof L, Zuberbier T, Henz BM (2004) Comparative cytokine profile of human skin mast cells from two compartments–strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming. J Leukoc Biol 75(2):244–252PubMedGoogle Scholar
  124. 124.
    Matsuda K, Piliponsky AM, Iikura M, Nakae S, Wang EW, Dutta SM, Kawakami T, Tsai M, Galli SJ (2005) Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response. J Allergy Clin Immunol 116(6):1357–1363PubMedGoogle Scholar
  125. 125.
    Simons FE (2010) World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings. Ann Allergy Asthma Immunol 104(5):405–412PubMedGoogle Scholar
  126. 126.
    Demain JG, Minaei AA, Tracy JM (2010) Anaphylaxis and insect allergy. Curr Opin Allergy Clin Immunol 10(4):318–322PubMedGoogle Scholar
  127. 127.
    Garman SC, Sechi S, Kinet JP, Jardetzky TS (2001) The analysis of the human high affinity IgE receptor Fc epsilon Ri alpha from multiple crystal forms. J Mol Biol 311(5):1049–1062PubMedGoogle Scholar
  128. 128.
    Leavy O Therapeutic antibodies: past, present and future. Nat Rev Immunol 10 (5):297Google Scholar
  129. 129.
    Chan AC, Carter PJ Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 10 (5):301–316Google Scholar
  130. 130.
    Bhattacharjee RN, Banerjee B, Akira S, Hande MP (2010) Telomere-mediated chromosomal instability triggers TLR4 induced inflammation and death in mice. PLoS One 5(7):e11873PubMedGoogle Scholar

Copyright information

© Springer Basel AG 2011

Authors and Affiliations

  • Jayapal Manikandan
    • 1
    • 2
  • Narasimhan Kothandaraman
    • 2
  • Manoor Prakash Hande
    • 1
    • 3
  • Peter Natesan Pushparaj
    • 2
    • 4
  1. 1.Department of Physiology, Yong Loo Lin School of MedicineNational University of SingaporeSingaporeSingapore
  2. 2.Center of Excellence in Genomic Medicine Research (CEGMR), King Fahad Medical Research CenterKing AbdulAziz UniversityJeddahSaudi Arabia
  3. 3.Tembusu College, University TownSingaporeSingapore
  4. 4.Institute of Immunity, Infection and Inflammation, College of Medicine, Veterinary and Life Sciences, 120 Glasgow Biomedical Research CentreUniversity of GlasgowGlasgowUK

Personalised recommendations